Drug reference
glimepiride-pioglitazone
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Drug class
Endocrine (Insulin secretagogues)
Mechanism of action
Initial effect to increase insulin secretion from beta cells; may also decrease rate of hepatic glucose production and increase insulin receptor sensitivity
Common side effects
- Upper respiratory tract infection
- Anemia
- Hypoglycemia
- Weight gain
- Peripheral edema
Related conditions
Frequently asked questions
What drug class is glimepiride-pioglitazone?
glimepiride-pioglitazone belongs to: Endocrine.
How does glimepiride-pioglitazone work?
Initial effect to increase insulin secretion from beta cells; may also decrease rate of hepatic glucose production and increase insulin receptor sensitivity
What are the common side effects of glimepiride-pioglitazone?
Upper respiratory tract infection, Anemia, Hypoglycemia, Weight gain, Peripheral edema
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.